Towards Healthcare

News

Your Daily Gateway to Essential News in Healthcare, Science, Technology and Business Worldwide

Vetter’s V-OVS® next tamper-evident syringe closure system to knock on the door of the healthcare sector
20 January 2026

Vetter’s V-OVS® next tamper-evident syringe closure system to knock on the door of the healthcare sector

Introduction Vetter, a well-known Contract Development and Manufacturing Organisation (CDMO), with a position of expertize of aseptic end-to-end process of injectable drugs, mainly for critical biologics such as vaccines and antibodies. Through this robust delivery, the company seals the deal with ...

North American Healthcare sector, a step ahead in the research area with the new TwinGuard® ECO 703VXH Freezer
20 January 2026

North American Healthcare sector, a step ahead in the research area with the new TwinGuard® ECO 703VXH Freezer

Introduction North American-based PHC Corporation, a division of Japan’s PHC Holdings, is a leading company heading strong with its PHCbi brand laboratory equipment, along with other robust CO2 incubators, refrigerators and ultra-low temperature freezers. The academic, government research cen...

Fosun and ElpasBio come together to promote AlloJoin® Stem Cell Therapy
19 January 2026

Fosun and ElpasBio come together to promote AlloJoin® Stem Cell Therapy

Introduction ElpasBio Holdings, a well-known, clinically promising biotechnology company, concentrates on regenerative medicine. This China-based company received its first recognition for its first stem cell drug, and the stamp of the FDA’s approval was a memorable milestone for the company....

Ainnocence’s new tech milestone grips speed in screening of infinitely small molecule and antibody candidates
19 January 2026

Ainnocence’s new tech milestone grips speed in screening of infinitely small molecule and antibody candidates

Introduction Ainnocence, a leading and smart biotech company known for its implementation of self-discovered AI tools/platforms and approaches to evolve drug discovery, has built trust among giants and existing healthcare companies for tech-based solutions. The popular platform, such as CarbonAI&re...

PharmaTher’s expansion to accelerate Ketamine and Psychedelic Patch Programs
19 January 2026

PharmaTher’s expansion to accelerate Ketamine and Psychedelic Patch Programs

Introduction PharmaTher Holdings Ltd. is a promising life sciences company committed to marketing, development and research of drug delivery systems and ketamine to cure pain disorders, neurodegenerative and neuropsychiatric disorders. With the company’s strength, KETARX, the approval has spe...

Paul Hudson’s desperation to secure vaccine space
19 January 2026

Paul Hudson’s desperation to secure vaccine space

Introduction Sanofi biopharmaceutical company, dives deep into the ocean of science to serve drugs, consumer healthcare products, and vaccines, prioritising the healthy life mission for patients suffering from rare diseases, cancer, diabetes, immunology condition. Across 130 countries, the company ...

Vy Spine to straighten its walk confidently with the FDA clearance for the VyBrate VBR System
16 January 2026

Vy Spine to straighten its walk confidently with the FDA clearance for the VyBrate VBR System

Introduction Vy Spine is a champion known for its exceptional designs and materials. This innovation leader was introduced to the healthcare sector via active internal development and the new qualified technologies that need innovative designs and materials. Overall, Vy Spine’s existence is b...

UC San Diego and Allele together in ARPA-H research project
16 January 2026

UC San Diego and Allele together in ARPA-H research project

Introduction Allele Biotechnology Company, known for its regenerative medicine and modern cell therapy, entered the competitive healthcare sector in 1999. The company is a face of Contract Development and Manufacturing Organisation (CDMO) mainly for cGMP induced pluripotent stem cells and relevant ...

AbbVie’s smart deal to avoid tariff storm in the near future
16 January 2026

AbbVie’s smart deal to avoid tariff storm in the near future

Introduction AbbVie biopharmaceutical company,’ hold its ground from the existence of Abbott Laboratories in 2013. The company is known for its innovative medicines for crucial diseases such as neuroscience, eye care, oncology and immunology. The popular smart partnerships and sharp R&D h...

Sentynl and Fortress ‘COMEBACK’ with its Menkes disease therapy
16 January 2026

Sentynl and Fortress ‘COMEBACK’ with its Menkes disease therapy

Introduction Sentynl Therapeutics, a U.S. biopharmaceutical company with its exclusive Zydus Lifesciences, centralising its aim at first place for establishing and introducing specialised, effective and innovative therapies for mainly rare diseases. Zydus Lifesciences is the parent company of Senty...